Lyme borreliosis

被引:21
作者
Schnarr, Sebastian
Franz, Juliane K.
Krause, Andreas
Zeidler, Henning [1 ]
机构
[1] Hannover Med Sch, Dept Internal Med, Div Rheumatol, D-3000 Hannover, Germany
[2] Rheumaklin Ostbayern, Bad Fuessing, Germany
[3] Privatklin Pk, Bad Schinznach, Switzerland
[4] Immanuel Hosp, Rheumakliniken Berlin Burch & Berlin Wannsee, Berlin, Germany
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2006年 / 20卷 / 06期
关键词
Lyme disease; Lyme borreliosis; Borrelia burgdorferi; epidemiology; pathogenesis; diagnosis; therapy; prevention; vaccine;
D O I
10.1016/j.berh.2006.08.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lyme borreliosis is a tick-borne infectious disease caused by the spirochaetes Borrelia burgdorferi, B. garinii and B. aftelii. It comprises a wide spectrum of symptoms affecting skin, musculoskeletal system, heart, eyes, central and peripheral nervous system. The diagnosis is based on clinical findings in combination with detection of specific IgM and/or IgG antibodies. Diagnostic problems arise from patients with non-specific symptoms and positive IgG antibody detection. Adequate antibiotic therapy cures more than 90% of the patients. However, in some patients repeated therapy is necessary and a small number of patients develop chronic arthritis or other features. While there is currently no vaccine available, prevention of tick bite is the most effective prophylaxis.
引用
收藏
页码:1099 / 1118
页数:20
相关论文
共 78 条
[1]   Diagnosis of Lyme borreliosis [J].
Aguero-Rosenfeld, ME ;
Wang, GQ ;
Schwartz, I ;
Wormser, GP .
CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (03) :484-+
[2]   Comparison of azithromycin and doxycycline in the treatment of erythema migrans [J].
Barsic, B ;
Maretic, T ;
Majerus, L ;
Strugar, J .
INFECTION, 2000, 28 (03) :153-156
[3]   Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis [J].
Borg, R ;
Dotevall, L ;
Hagberg, L ;
Maraspin, V ;
Lotric-Furlan, S ;
Cimperman, J ;
Strle, F .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2005, 37 (6-7) :449-454
[4]  
Campbell GL, 1998, AM J EPIDEMIOL, V148, P1018, DOI 10.1093/oxfordjournals.aje.a009568
[5]  
Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590
[6]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P365
[7]   Treatment of Lyme arthritis [J].
Cimmino, MA ;
Moggiana, GL ;
Parisi, M ;
Accardo, S .
INFECTION, 1996, 24 (01) :91-94
[8]  
DATTWYLER RJ, 1988, LANCET, V1, P1191
[9]   Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease [J].
Dattwyler, RJ ;
Luft, BJ ;
Kunkel, MJ ;
Finkel, MF ;
Wormser, GP ;
Rush, TJ ;
Grunwaldt, E ;
Agger, WA ;
Franklin, M ;
Oswald, D ;
Cockey, L ;
Maladorno, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (05) :289-294
[10]   AMOXYCILLIN PLUS PROBENECID VERSUS DOXYCYCLINE FOR TREATMENT OF ERYTHEMA MIGRANS BORRELIOSIS [J].
DATTWYLER, RJ ;
VOLKMAN, DJ ;
CONATY, SM ;
PLATKIN, SP ;
LUFT, BJ .
LANCET, 1990, 336 (8728) :1404-1406